Skip to content

Fresenius Medical Care employee in Schweinfurt is Germany’s best apprentice in her specialty as electronics technician

| Press release

Press release

Melanie Schmitt of Fresenius Medical Care in Schweinfurt is Germany’s best apprentice in the category “Electronics Technician for Information and Systems Technology.” This annual award from the Association of German Chambers of Industry and Commerce was based on her outstanding examination results at the end of a three-and-a-half-year training period. Schmitt, 20, was also honored for the best vocational qualification in the State of Bavaria and the Main-Franconia region.

Between September 2016 and February 2020, Schmitt trained in various departments in production and in research and development at Fresenius Medical Care’s facility in Schweinfurt. She learned to develop and program electronic switches and other hardware and software components. The Schweinfurt resident is now working in the software and systems verification department of the Global Research and Development division.

“If I do something, then I like to do it right,” Schmitt said, explaining her outstanding results to the small group gathered for the award presentation at the Schweinfurt plant. An annual ceremony is normally held in Berlin to honor all the apprentice winners from across Germany, but it had to be canceled this year due to the pandemic.

“As the local chamber, state and federal winner, Melanie Schmitt accomplished a gigantic feat,” said Jürgen Bode, Deputy Director of the Würzburg-Schweinfurt Chamber of Industry and Commerce, who presented the award. “This required good cooperation between the apprentice and the company providing the training. My thanks to Fresenius Medical Care, who have accomplished this superbly.”

Christian Hepp, head of industrial training at Fresenius Medical Care in Schweinfurt, said: “Quality in training is very important to us. We are really delighted, along with Melanie Schmitt, about this special award. And we are honored that she has decided on a future with us.”

During industrial and commercial training at Fresenius Medical Care in Schweinfurt, apprentices, trainees and students in dual-study programs work on various projects together with engineers and other experts. Assignments have a specific practical application, and there are few purely academic exercises.

Opened in 1979, the Schweinfurt facility is Fresenius Medical Care’s most important research and production facility for dialysis machines and other medical devices. The company currently has more than 1,300 employees at the site, about a third of them in research and development.

 

Press Photo

 

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,073 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 349,167 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit the Company’s website at www.freseniusmedicalcare.com.

Disclaimer

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.